Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01047046 · ClinicalTrials.gov registry record
Combined Anticholinergic Medication and Sacral Neuromodulation to Treat Refractory Overactive Bladder
A clinical trial of Overactive Bladder, sponsored by University of California, Irvine.
- Completed
- Registry status
- 88
- Enrollment target
- 1
- Study location
NCT01047046 is a study of Overactive Bladder that has completed, run by University of California, Irvine. The registered enrollment target is 88 participants, below the 210-participant average among 45 other Overactive Bladder trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01047046, a study of Overactive Bladder, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a retrospective chart review including all patients who received surgical placement of a SNM device with Dr. Noblett from 2001 to the present.
Conditions Studied
Interventions
- OTHER Retrospective chart review
Study Locations (1)
California
- UCI Women's Healthcare - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01047046
The ClinicalTrials.gov registry entry for NCT01047046 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 210-participant average among 45 other Overactive Bladder trials with a reported enrollment target (58% lower). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Overactive Bladder appearing as the primary indexed condition, and to 1 intervention - of which Retrospective chart review is the first listed.
NCT01047046 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01047046 about?
NCT01047046 is a clinical study titled "Combined Anticholinergic Medication and Sacral Neuromodulation to Treat Refractory Overactive Bladder". This study is a retrospective chart review including all patients who received surgical placement of a SNM device with Dr. Noblett from 2001 to the present.
What is the current status of trial NCT01047046?
This trial is currently completed. The enrollment target is 88 participants. The study started on 2008-01. Estimated completion is 2009-12.
What conditions does trial NCT01047046 study?
This clinical trial studies the following conditions: Overactive Bladder.
What interventions are being tested in trial NCT01047046?
The interventions under investigation include: Retrospective chart review (OTHER).
Who is sponsoring clinical trial NCT01047046?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01047046 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overactive Bladder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead
RECRUITING · NA
-
Bladder Botox UTI Antibiotic Prophylaxis
RECRUITING · Phase 4
-
Percutaneous Nerve Evaluation Trial Time
RECRUITING · NA
-
Noninvasive Ultrasound Assessment of Detrusor Dysfunction
RECRUITING
-
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RECRUITING · NA
-
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.